{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/MASI/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-22T11:59:07.155Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8937,"canonical_name":"MASIMO CORP","cik":"0000937556","uei":null,"lei":null,"duns":null,"ticker":"MASI"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":26,"clinical":2,"open":1},"count":29,"timeline":[{"ts":"2026-06-22","kind":"sec.filing","form_type":"15-12G","title":"15-12G — MASIMO CORP — 2026-06-22","url_slug":"/sec/cik-0000937556/15-12g/0001104659-26-076448","accession_number":"0001104659-26-076448","importance":30},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Politan Capital Management LP","title":"","shares":4590873,"price_per_share":180,"usd_value":826357140,"security_title":"Common Stock","importance":55},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Koffey Quentin","title":"","shares":4590873,"price_per_share":180,"usd_value":826357140,"security_title":"Common Stock","importance":55},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Politan Capital Partners GP LLC","title":"","shares":4590873,"price_per_share":180,"usd_value":826357140,"security_title":"Common Stock","importance":55},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Politan Capital Management GP LLC","title":"","shares":4590873,"price_per_share":180,"usd_value":826357140,"security_title":"Common Stock","importance":55},{"ts":"2026-06-10","kind":"sec.filing","form_type":"8-K","title":"8-K — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/8-k/0001104659-26-072151","accession_number":"0001104659-26-072151","importance":35},{"ts":"2026-06-10","kind":"sec.filing","form_type":"POSASR","title":"POSASR — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/posasr/0001104659-26-072329","accession_number":"0001104659-26-072329","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/s-8-pos/0001104659-26-072335","accession_number":"0001104659-26-072335","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/s-8-pos/0001104659-26-072337","accession_number":"0001104659-26-072337","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/s-8-pos/0001104659-26-072338","accession_number":"0001104659-26-072338","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/s-8-pos/0001104659-26-072349","accession_number":"0001104659-26-072349","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/s-8-pos/0001104659-26-072352","accession_number":"0001104659-26-072352","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/s-8-pos/0001104659-26-072356","accession_number":"0001104659-26-072356","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/s-8-pos/0001104659-26-072360","accession_number":"0001104659-26-072360","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/s-8-pos/0001104659-26-072361","accession_number":"0001104659-26-072361","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/s-8-pos/0001104659-26-072362","accession_number":"0001104659-26-072362","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — MASIMO CORP — 2026-06-10","url_slug":"/sec/cik-0000937556/s-8-pos/0001104659-26-072365","accession_number":"0001104659-26-072365","importance":30},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Sampath Anand","title":"EVP, Operations","shares":33901,"price_per_share":180,"usd_value":6102180,"security_title":"Common Stock","importance":21.10218},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Young Micah W","title":"EVP, Chief Financial Officer","shares":25656,"price_per_share":180,"usd_value":4618080,"security_title":"Common Stock","importance":19.61808},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Hataishi Paul","title":"SVP, Chief Accounting Officer","shares":13317,"price_per_share":180,"usd_value":2397060,"security_title":"Common Stock","importance":17.39706},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Brennan Michelle","title":"","shares":9309,"price_per_share":180,"usd_value":1675620,"security_title":"Common Stock","importance":16.67562},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Szyman Catherine M.","title":"Chief Executive Officer","shares":7605,"price_per_share":180,"usd_value":1368900,"security_title":"Common Stock","importance":16.3689},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Solomon Darlene J. S.","title":"","shares":3015,"price_per_share":180,"usd_value":542700,"security_title":"Common Stock","importance":15.5427},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"LANE WENDY E","title":"","shares":2608,"price_per_share":180,"usd_value":469440,"security_title":"Common Stock","importance":15.46944},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Scannell Timothy J","title":"","shares":2608,"price_per_share":180,"usd_value":469440,"security_title":"Common Stock","importance":15.46944},{"ts":"2026-06-10","kind":"sec.insider.d","reporter":"Hellmann Elisabeth A","title":"Chief Human Resources Officer","shares":214,"price_per_share":180,"usd_value":38520,"security_title":"Common Stock","importance":15.03852},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Masimo Corporation","title":"Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)","security_title":"NA","status":"RECRUITING","accession_number":"NCT06432881","excerpt":"[\"Hypoxemia\"]","importance":25},{"ts":"2026-04-02","kind":"clinical.trial","reporter":"Masimo Corporation","title":"Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation","security_title":"NA","status":"COMPLETED","accession_number":"NCT06148623","excerpt":"[\"Healthy\"]","importance":25},{"ts":"2024-12-31","kind":"open.payments","reporter":"Masimo Corporation","title":"$867561.0 to 1053 physicians (2024–2024)","security_title":"manufacturer","excerpt":"Patient SafetyNet System","accession_number":"2024","usd_value":867561,"importance":70}]}